Login / Signup

Alpha-fetoprotein elevation in NUT midline carcinoma: a case report.

Lorenzo D'AmbrosioErica PalesandroMarina MorettiGiuseppe PelosiAlessandra FabbriFabrizio Carnevale SchiancaMassimo AgliettaGiovanni Grignani
Published in: BMC cancer (2017)
The life-threatening aggressiveness of NUT midline carcinoma mandates to reach the right diagnosis in the shortest possible time. In this regard, poorly differentiated carcinomas lacking glandular differentiation mandate testing for NUT expression by immunohistochemistry. Awareness of a potentially misleading tumor marker elevation can help to broaden the differential diagnosis and establish the most appropriate treatment.
Keyphrases
  • poor prognosis
  • binding protein
  • combination therapy
  • smoking cessation